01.05.2015 Views

Medical Research: A Consumer's Guide for Participation

Medical Research: A Consumer's Guide for Participation

Medical Research: A Consumer's Guide for Participation

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Maine<br />

Legislation: 24-A: Maine Insurance Code<br />

Effective: 1999<br />

What clinical trials are covered? Clinical trials<br />

enrolling individuals who have a life-threatening or<br />

serious illness <strong>for</strong> which no standard treatment is<br />

effective. Trial must be approved and funded by any<br />

one of the following:<br />

• National Institutes of Health (NIH)<br />

• NIH-sponsored cooperative group or center<br />

• U.S. Department of Health and Human<br />

Services<br />

Who is required to pay? Managed care organizations<br />

and private insurers.<br />

Other key provisions:<br />

• <strong>Participation</strong> must offer meaningful potential<br />

<strong>for</strong> significant clinical benefit to the enrollee.<br />

• Referring physician must conclude that trial<br />

participation is appropriate.<br />

Massachusetts<br />

Legislation: House Bill 4376 (Chapter 257)<br />

Effective: January 2003<br />

What clinical trials are covered? All phases of cancer<br />

treatment trials. Trial must be peer-reviewed and<br />

approved by one of the following:<br />

• National Institutes of Health (NIH)<br />

• NIH-sponsored cooperative group or center<br />

• U.S. Department of Defense<br />

• U.S. Department of Veterans Affairs<br />

• U.S. Food and Drug Administration<br />

• A qualified non-government research entity<br />

Who is required to pay? All health plans issued or<br />

renewed after January 1, 2003.<br />

Other key provisions:<br />

• Insurers must provide payment <strong>for</strong> services<br />

that are “consistent with the usual and<br />

customary standard of care” provided under<br />

the trial’s protocol and that would be covered<br />

if the patient did not participate in the trial.<br />

Michigan<br />

Agreement: Michigan Consensus Agreement<br />

Effective: February 2002<br />

What clinical trials are covered? Phase II and III<br />

cancer clinical trials that are sponsored or approved<br />

by any one of the following:<br />

• National Institutes of Health (NIH)<br />

• National Cancer Institute<br />

• U.S. Food and Drug Administration<br />

• U.S. Department of Defense<br />

• U.S. Department of Veterans Affairs<br />

• Centers <strong>for</strong> Medicare and Medicaid Services<br />

• Centers <strong>for</strong> Disease Control and Prevention<br />

• The agreement also would cover any side<br />

effects from the clinical trial treatment,<br />

including hospitalization costs.<br />

Who is required to pay? Private insurance plans,<br />

HMOs and the Michigan Medicaid Program.<br />

Other key provisions:<br />

• Coverage <strong>for</strong> Phase I trials is under<br />

consideration.<br />

Missouri<br />

Legislation: Senate Bill 1026; Senate Bills 567 & 792<br />

Effective: August 28, 2002 (S.B. 1026); May 12, 2006<br />

(S.B. 567 & 792)<br />

What clinical trials are covered? Phase II, III or IV<br />

clinical trials <strong>for</strong> the prevention, early detection, or<br />

treatment of cancer as approved or funded by one of<br />

the following:<br />

• National Institutes of Health (NIH)<br />

• NIH Cooperative Group or Center<br />

• U.S. Food and Drug Administration<br />

• U.S. Department of Defense<br />

• U.S. Department of Veterans Affairs<br />

• An Institutional Review Board in Missouri that<br />

has been approved by the U.S. Department of<br />

Health and Human Services<br />

• A qualified research entity that meets the<br />

criteria <strong>for</strong> NIH Center support grant eligibility<br />

Who is required to pay? All health benefit plans operating<br />

in the state.<br />

Other key provisions:<br />

• There must be identical or superior noninvestigational<br />

treatment alternatives available be<strong>for</strong>e<br />

26

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!